Cost-effectiveness of MicroRNA for Pancreatic Cancer Screening in Patients With Diabetes
Sign Up to like & getrecommendations! Published in 2022 at "Pancreas"
DOI: 10.1097/mpa.0000000000002130
Abstract: Objectives The study aimed to assess the cost-effectiveness of microRNA compared with carbohydrate antigen 19-9, abdominal ultrasound, magnetic resonance imaging, endoscopic ultrasound, computed tomography, positron emission tomography, and no screening for pancreatic cancer (PC) screening… read more here.
Keywords: pancreatic cancer; cost; effectiveness microrna; cancer screening ... See more keywords